Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab)

被引：0
|
作者：
Musette, P
Mouquet, H
Jacquot, S
Gilbert, D
Huetz, F
Roujeau, JC
D'Incan, M
Tron, F
Joly, P
机构：
[1] INSERM U519, Paris, France
[2] Inst Pasteur, Paris, France
[3] CHU Creteil, Creteil, France
[4] CHU Clermont Ferrand, Clermont Ferrand, France
[5] CHU Rouen, Rouen, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2005年 / 125卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
076
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [21] Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine
    Lamure, Sylvain
    Chavez, Houria Hendel
    de Goer de Herve, Marie-Ghislaine
    Fornecker, Luc-Matthieu
    Drenou, Bernard
    Jacquet, Caroline
    Merabet, Fatiha
    Kohn, Milena
    Quelin, Florence
    Jackson, Angela
    Choquet, Sylvain
    Dulery, Remy
    Taoufik, Yassine
    Besson, Caroline
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [22] Influence of Body Mass Index on B Lymphocyte Repopulation in Multiple Sclerosis Patients Treated with Anti-CD20 Therapy
    Loeffler, Jacob
    Han, May
    NEUROLOGY, 2023, 100 (17)
  • [23] Modulation of gene expression profiles of pbmc in rheumatoid arthritis patients treated with anti-CD20 (rituximab)
    Drynda, S.
    Koczan, D.
    Thiesen, H. J.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A29 - A29
  • [24] Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study
    Solak, Eda Oksum
    Gokcek, Gozde Emel
    Cinar, Salih Levent
    Kartal, Demet
    Borlu, Murat
    ERCIYES MEDICAL JOURNAL, 2021, 43 (03) : 267 - 272
  • [25] B cell populations in the myasthenia thymus that bind Rituximab (anti-CD20)
    Zainudeen, Z.
    Attfield, K.
    Willcox, N.
    Vincent, A.
    IMMUNOLOGY, 2014, 143 : 186 - 186
  • [26] B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
    Shaw, T
    Quan, J
    Totoritis, MC
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 59
  • [27] Is Efficacy of the Anti-Cd20 Antibody Rituximab Preventing Hemolysis Due to Passenger Lymphocyte Syndrome?
    Tsujimura, Kazuma
    Ishida, Hideki
    Tanabe, Kazunari
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (01) : 22 - 25
  • [28] A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
    Saleh, MN
    Gutheil, J
    Moore, M
    Bunch, PW
    Butler, J
    Kunkel, L
    Grillo-López, AJ
    LoBuglio, AF
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 99 - 103
  • [29] Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab
    Chen, Lucia Y.
    Shah, Raakhee
    Cwynarski, Kate
    Lambert, Jonathan
    McNamara, Christopher
    Mohamedbhai, Sajir G.
    Virchis, Andres
    Townsend, William
    D'Sa, Shirley
    Ardeshna, Kirit M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (03) : 462 - 465
  • [30] Autoreactive B-cells phenotype analysis in pemphigus patients before and after anti-CD20 treatment
    Vaillant, M. Maho
    Golinsky, M.
    Caillot, F.
    Hebert, V.
    Petit, M.
    Riou, G.
    Boyer, O.
    Joly, P.
    Calbo, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S199 - S199
12345